These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10328989)

  • 1. Searching for the ideal SERM.
    Poletti A
    Pharmacol Res; 1999 May; 39(5):333. PubMed ID: 10328989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of SERM and SAS (tibolone) on breast tissue].
    Gompel A; Jacob D; de Chambine S; Mimoun M; Decroix Y; Rostene W; Poitout P
    Contracept Fertil Sex; 1999 May; 27(5):368-75. PubMed ID: 10401183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of the perfect SERM: beyond tamoxifen and raloxifene.
    McNeil C
    J Natl Cancer Inst; 1998 Jul; 90(13):956-7. PubMed ID: 9665139
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.
    Lykkesfeldt AE
    Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
    Newby JC; Johnston SR; Smith IE; Dowsett M
    Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: In search of the perfect SERM: beyond tamoxifen and raloxifene.
    Williams GM
    J Natl Cancer Inst; 1998 Nov; 90(21):1671. PubMed ID: 9811319
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen and the endometrium.
    Barakat RR
    Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog?
    Gelmann EP
    J Natl Cancer Inst; 1996 Mar; 88(5):224-6. PubMed ID: 8613997
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
    Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New vs old fashioned oestradiol antagonists in mammary carcinoma: 'in vitro' and 'in vivo' pharmacological approaches.
    de Cupis A; Schettini G; Favoni RE
    Pharmacol Res; 1999 May; 39(5):335-44. PubMed ID: 10328990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone therapy and breast cancer].
    de Cremoux P
    Bull Cancer; 2011 Nov; 98(11):1311-9. PubMed ID: 22020743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group.
    Lundin AC; Söderkvist P; Eriksson B; Bergman-Jungeström M; Wingren S
    Cancer Res; 1999 May; 59(10):2332-4. PubMed ID: 10344739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in endocrine therapy of breast cancer.
    Howell A; Dowsett M
    BMJ; 1997 Oct; 315(7112):863-6. PubMed ID: 9353509
    [No Abstract]   [Full Text] [Related]  

  • 15. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-hormonal therapy in breast cancer].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
    [No Abstract]   [Full Text] [Related]  

  • 17. Searching for evidence of altered gene expression: a comment on statistical analysis of microarray data.
    Wittes J; Friedman HP
    J Natl Cancer Inst; 1999 Mar; 91(5):400-1. PubMed ID: 10070933
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of toremifene in breast cancer patients. Preliminary communication.
    Hindy I; Juhos E; Szántó J; Számel I
    J Steroid Biochem; 1990 Jun; 36(3):225-6. PubMed ID: 2142238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological rationale for endocrine therapy in breast cancer.
    Miller WR
    Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):1-32. PubMed ID: 14687595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogen therapy: uncertainties and risk assessment.
    Smith LL; White IN
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):14-22. PubMed ID: 9556786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.